Sumitomo Mitsui DS Asset Management Company Ltd lifted its position in Molina Healthcare, Inc (NYSE:MOH - Free Report) by 22.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,289 shares of the company's stock after purchasing an additional 1,333 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in Molina Healthcare were worth $2,401,000 at the end of the most recent reporting period.
A number of other large investors have also modified their holdings of MOH. Smartleaf Asset Management LLC raised its stake in Molina Healthcare by 123.9% during the fourth quarter. Smartleaf Asset Management LLC now owns 347 shares of the company's stock worth $100,000 after acquiring an additional 192 shares in the last quarter. Farther Finance Advisors LLC raised its stake in Molina Healthcare by 100.3% during the first quarter. Farther Finance Advisors LLC now owns 659 shares of the company's stock worth $216,000 after acquiring an additional 330 shares in the last quarter. Raymond James Financial Inc. acquired a new position in Molina Healthcare during the fourth quarter worth $10,725,000. US Bancorp DE raised its stake in Molina Healthcare by 22.3% during the fourth quarter. US Bancorp DE now owns 1,993 shares of the company's stock worth $580,000 after acquiring an additional 364 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC raised its stake in Molina Healthcare by 82.1% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 15,635 shares of the company's stock worth $5,150,000 after acquiring an additional 7,051 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of analysts have recently weighed in on MOH shares. Guggenheim started coverage on Molina Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating for the company. Wall Street Zen lowered Molina Healthcare from a "buy" rating to a "hold" rating in a research note on Sunday, June 29th. Truist Financial raised their price target on Molina Healthcare from $340.00 to $400.00 and gave the company a "buy" rating in a report on Friday, April 11th. Barclays decreased their price target on Molina Healthcare from $351.00 to $347.00 and set an "equal weight" rating on the stock in a report on Monday, June 9th. Finally, Mizuho raised their price target on Molina Healthcare from $376.00 to $400.00 and gave the company an "outperform" rating in a report on Wednesday, April 9th. Ten analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $364.21.
Check Out Our Latest Stock Analysis on MOH
Insider Buying and Selling at Molina Healthcare
In other news, CEO Joseph M. Zubretsky sold 87,500 shares of the stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $320.06, for a total value of $28,005,250.00. Following the sale, the chief executive officer directly owned 257,715 shares of the company's stock, valued at approximately $82,484,262.90. This represents a 25.35% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Richard M. Schapiro sold 669 shares of the stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $320.50, for a total transaction of $214,414.50. Following the completion of the sale, the director directly owned 11,244 shares in the company, valued at approximately $3,603,702. The trade was a 5.62% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.10% of the stock is currently owned by insiders.
Molina Healthcare Price Performance
Shares of MOH opened at $239.51 on Friday. The business has a 50-day moving average of $302.25 and a 200-day moving average of $305.47. Molina Healthcare, Inc has a 1 year low of $236.37 and a 1 year high of $365.23. The company has a market capitalization of $12.98 billion, a price-to-earnings ratio of 11.56, a price-to-earnings-growth ratio of 0.80 and a beta of 0.55. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.63 and a quick ratio of 1.63.
Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, April 23rd. The company reported $6.08 EPS for the quarter, topping the consensus estimate of $5.96 by $0.12. Molina Healthcare had a return on equity of 28.38% and a net margin of 2.81%. The business had revenue of $11.15 billion during the quarter, compared to analysts' expectations of $10.86 billion. During the same quarter last year, the firm posted $5.73 earnings per share. The firm's revenue was up 12.2% on a year-over-year basis. As a group, equities research analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.
About Molina Healthcare
(
Free Report)
Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.
Read More
Want to see what other hedge funds are holding MOH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Molina Healthcare, Inc (NYSE:MOH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Molina Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Molina Healthcare wasn't on the list.
While Molina Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.